Articles

On December 3, 2019, the FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to the biopharmaceutical company Adaptimmune Therapeutics for ADP-A2M4 for the treatment of synovial sarcoma. Earlier this year, the FDA granted Orphan Drug designation to the agent for the treatment of soft tissue sarcomas. Read More ›

"Guidelines offer all possible scenarios, while pathways comprise the details. The whole objective is to facilitate quality care in all aspects of the patient interaction, including their evaluation, prevention, treatment, education, supportive care, and end-of-life. Nevertheless, there’s still some mixing of definitions across the spectrum,” said Linda D. Bosserman, MD, FACP, FASCO. Read More ›

Cancer care can be provided by many types of institutions, from large comprehensive cancer centers to small rural hospitals. In this issue of The Oncology Nurse-APN/PA (TON), we are focusing on a rural cancer center in Appalachia—the Adena Cancer Center, Chillicothe, OH, which is part of the Adena Health System. Adena has a main campus, where the cancer center is situated at Adena Regional Medical Center, as well as 2 additional critical access hospitals in Greenfield and Waverly. Together, they serve the health needs of 9 counties in south central and southern Ohio. Read More ›